Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,949 | -33,361 | -15,876 | -16,280 | -15,385 |
| Depreciation Amortization | 8,933 | 52,284 | 40,950 | 27,276 | 14,021 |
| Income taxes - deferred | 8,754 | 20,723 | -25,570 | -12,925 | -16,180 |
| Accounts receivable | 1,099 | 55,319 | 20,550 | 23,208 | 43,638 |
| Other Working Capital | 7,897 | 65,677 | 39,105 | 34,094 | 48,791 |
| Other Operating Activity | -34,684 | -22,792 | 25,219 | 8,516 | -22,874 |
| Operating Cash Flow | $33,948 | $137,850 | $84,378 | $63,889 | $52,011 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,833 | 182,415 | 187,580 | 163,912 | 119,506 |
| PPE Investments | -2,414 | -17,923 | -15,792 | -11,463 | -4,875 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -750 |
| Purchase Of Investment | N/A | N/A | N/A | -750 | N/A |
| Purchase Sale Intangibles | 130 | 92 | N/A | N/A | N/A |
| Other Investing Activity | 130 | -868 | -880 | 33 | 0 |
| Investing Cash Flow | $10,549 | $163,624 | $170,908 | $151,732 | $113,881 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 202 | N/A | N/A | N/A |
| Debt Repayment | -13 | -260,949 | N/A | -223,303 | -163,356 |
| Common Stock Issued | 3,393 | 3,232 | 1,831 | 1,011 | 347 |
| Common Stock Repurchased | N/A | N/A | -260,949 | N/A | N/A |
| Other Financing Activity | -4,155 | -18,475 | -11,574 | -7,571 | -7,412 |
| Financing Cash Flow | $-775 | $-275,990 | $-270,692 | $-229,863 | $-170,421 |
| Beginning Cash Position | 45,006 | 19,522 | 19,522 | 19,522 | 19,522 |
| End Cash Position | 88,728 | 45,006 | 4,116 | 5,280 | 14,993 |
| Net Cash Flow | $43,722 | $25,484 | $-15,406 | $-14,242 | $-4,529 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,948 | 137,850 | 84,378 | 63,889 | 52,011 |
| Capital Expenditure | -2,414 | -17,923 | -15,792 | -11,463 | -4,875 |
| Free Cash Flow | 31,534 | 119,927 | 68,586 | 52,426 | 47,136 |